Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew revision identifier v3.3.2 is shown, replacing the previous v3.2.0. This change does not affect study data, eligibility criteria, endpoints, or trial status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedDeleted a banner warning that, due to a lapse in government funding, the information on this website may not be up to date and NIH operations could be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03689829. The page content and structure appear unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedVersion bumped to v3.2.0 with an important status notice about potential gaps due to funding, and references to official status pages; previous v3.1.0 was removed.SummaryDifference2%

- Check78 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference0.4%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.1%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.